Titre : | Prevalence of Smoking Assessed Biochemically in an Urban Public Hospital : A Rationale for Routine Cotinine Screening. (2009) |
Auteurs : | Neal-L BENOWITZ ; Katherine-M DAINS ; Christine-A Haller ; Peyton-Iii Jacob ; Katherine-E SCHULTZ ; Alan-Hb WU ; Department of Laboratory Medicine. School of Medicine. University of California. San Francisco. CA. USA ; Departments of Medicine and Biopharmaceutical Sciences. Schools of Medicine and Pharmacy. University of California. San Francisco. CA. USA ; Division of Clinical Pharmacology and Experimental Therapeutics. Medical Service. San Francisco General Hospital Medical Center. San Francisco. CA. USA |
Type de document : | Article |
Dans : | American journal of epidemiology (vol. 170, n° 7, 2009) |
Pagination : | 885-891 |
Langues: | Anglais |
Mots-clés : | Tabagisme ; Prévalence ; Tabac ; Marqueur tabagisme ; Hôpital ; Hospitalisation ; Milieu urbain ; Dépistage ; Ethnie ; Pollution ; Vulnérabilité ; Population ; Epidémiologie ; Homme ; Médicament psychotrope ; Antidépresseur ; Fumée tabac |
Résumé : | [BDSP. Notice produite par INIST-CNRS R0xJFJ7p. Diffusion soumise à autorisation]. Cotinine, a metabolite of nicotine, has been used to study tobacco smoke exposure in population studies, but the authors are unaware of its use to screen hospitalized patients. The authors measured serum cotinine levels in 948 patients admitted to an urban public hospital in San Francisco, California, between September 2005 and July 2006. On the basis of cotinine levels, they classified patients as active smokers (cotinine>=14 ng/mL), recent smokers or significantly exposed to secondhand smoke (SHS) (0.5-13.9 ng/mL), lightly exposed to SHS (0.05-0.49 ng/mL), or unexposed ( |